Sawicka, M.M.; Sawicki, K.; Jadeszko, M.; Bielawska, K.; Supruniuk, E.; Reszeć, J.; Prokop-Bielenia, I.; Polityńska, B.; Jadeszko, M.; Rybaczek, M.;
et al. Proline Metabolism in WHO G4 Gliomas Is Altered as Compared to Unaffected Brain Tissue. Cancers 2024, 16, 456.
https://doi.org/10.3390/cancers16020456
AMA Style
Sawicka MM, Sawicki K, Jadeszko M, Bielawska K, Supruniuk E, Reszeć J, Prokop-Bielenia I, Polityńska B, Jadeszko M, Rybaczek M,
et al. Proline Metabolism in WHO G4 Gliomas Is Altered as Compared to Unaffected Brain Tissue. Cancers. 2024; 16(2):456.
https://doi.org/10.3390/cancers16020456
Chicago/Turabian Style
Sawicka, Magdalena M., Karol Sawicki, Marek Jadeszko, Katarzyna Bielawska, Elżbieta Supruniuk, Joanna Reszeć, Izabela Prokop-Bielenia, Barbara Polityńska, Mateusz Jadeszko, Magdalena Rybaczek,
and et al. 2024. "Proline Metabolism in WHO G4 Gliomas Is Altered as Compared to Unaffected Brain Tissue" Cancers 16, no. 2: 456.
https://doi.org/10.3390/cancers16020456
APA Style
Sawicka, M. M., Sawicki, K., Jadeszko, M., Bielawska, K., Supruniuk, E., Reszeć, J., Prokop-Bielenia, I., Polityńska, B., Jadeszko, M., Rybaczek, M., Latoch, E., Gorbacz, K., Łysoń, T., & Miltyk, W.
(2024). Proline Metabolism in WHO G4 Gliomas Is Altered as Compared to Unaffected Brain Tissue. Cancers, 16(2), 456.
https://doi.org/10.3390/cancers16020456
